Goldman Sachs' Chris Shibutani talks his top biotech picks including Eli Lilly and Pfizer Published 2023-09-29 Download video MP4 360p Download video MP4 720p Recommendations 19:02 Pfizer CEO Bourla on R&D, Obesity Drugs, and Winning Back Investors | At Barron's 05:52 Biotech boom ahead in 2024, top Jefferies analyst predicts on heels of Bristol Meyers-Karuna deal 07:43 Former Treasury Secretary Mnuchin: I'm going to put together a group to buy TikTok 19:35 Pfizer CEO on Sales, M&A, mRNA, Weight Loss Drug 10:06 The Rise And Fall Of Goldman Sachs' Marcus 05:35 Billionaire investor Ken Langone: Lilly will be the first trillion dollar drug company in history 04:46 There's a crop of great biotech companies ready to be acquired, says MPM's Christiana Bardon 09:36 Warren Buffett: Mistakes Made At GE | CNBC 05:58 We see Big Pharma going after smaller biotechs in 2024, says Jefferies' Michael Yee 28:43 Samarth Kulkarni, CEO, CRISPR Therapeutics 08:27 Why Interest Rates Take So Long To Affect The Economy 06:50 What Triggered the Crash in India's Stock Market: All You Need to Know | Vantage with Palki Sharma 05:36 Biotech is the biggest bull market in A.I., says Lux Capital's Josh Wolfe 09:27 Warren Buffett: It's Insane To Risk What You Have For Something You Don't Need | CNBC 13:53 Eli Lilly's Pipeline Unveiled & LLY Stock Analysis Breakdown 05:52 Expectations for Pfizer have been low, says Mizuho's Jared Holz on weight-loss pill setback 12:25 2023 and Beyond: The Future of Biotech 09:08 The AI dark horse: Why Apple could win the next evolution of the AI arms race Similar videos 08:41 The $100 billion dollar opportunity in obesity drugs, Goldman Sachs analyst explains 04:24 We've only seen the beginning of Moderna's story, says Goldman Sachs' Salveen Richter 00:41 Jim Cramer on the huge potential for Eli Lilly's answer to Ozempic #Shorts 01:24 Bridging the Gap Between Biomarker Testing and Treatment 04:39 Eli Lilly settles whistleblower lawsuit over manufacturing problems | ANC 01:00 Great acquisition for Eli Lilly #stockmarket 13:41 Al Arabiya full interview with Head of Oil Research at Goldman Sachs 02:47 Why Pfizer is a top stock pick again | Smart Investing 05:05 Would You Rather Buy Nvidia or Eli Lilly? | Guy Adami on CNBC's Fast Money 01:18 Why is Pfizer buying cancer drug maker Seagen for $43 billion? 06:42 MRNA, PFE: Should Health Care Stocks Stop Focusing On Covid? 00:19 🚨BREAKING: Novo Nordisk wins #semaglutide patent challenge 03:28 Pfizer warns of delayed Paxlovid commercialization and lower Covid demand 13:56 Maia Shibutani: How to Navigate Anxiety as an Athlete | You Got this | Child Mind Institute 03:23 We will 'absolutely' see earnings growth in 2024: Citi's Kristen Bitterly 11:54 Five Best Biotech Stocks to Invest in 2023 | YTD Performers 04:36 UnitedHealth (UNH) Has Strong 3Q & Pfizer (PFE) Nears Lows As Vaccine Demand Falls More results